These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An embargoed Cuban science. Smith C Genet Anal; 1999 Nov; 15(3-5):71-2. PubMed ID: 10596742 [No Abstract] [Full Text] [Related]
5. Kiran Mazumdar-Shaw. Mazumdar-Shaw K Nat Rev Drug Discov; 2010 Jul; 9(7):510. PubMed ID: 20592739 [No Abstract] [Full Text] [Related]
6. Real options for biotechnology valuation. Harrison M; Lerer L Nat Biotechnol; 2002 Mar; 20(3):223-4. PubMed ID: 11875412 [No Abstract] [Full Text] [Related]
7. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp. Sharer K Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953 [TBL] [Abstract][Full Text] [Related]
17. France critiques its incubator before refinancing. Louët S Nat Biotechnol; 2004 Jan; 22(1):126. PubMed ID: 14725299 [No Abstract] [Full Text] [Related]
18. New pharma-biotech company formation in India. Saberwal G Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124 [No Abstract] [Full Text] [Related]